CSIR-Institute of Himalayan Bioresource Technology (CSIR IHBT) invited applications for recruitment to the post for SRF, Project Fellow, and Project Assistant. The candidates eligible for the post can walk in for the Interview on 20 July 2016 (09.30 AM).
Under CSIR IHBT Recruitment 2016 out of total 08 posts, 01 Post is for SRF, 04 Posts are for Project Assistant Level- II, 01 Post is for Project Fellow and 02 Posts are for Project Assistant Level –I.
Eligibility for Sr. Research Fellow: candidate should have M.Sc in Organic Chemistry with minimum 55% and should have 02 Years Post qualification research experience.
Eligibility for Project Assistant Level II: candidate should have M.Sc in Chemistry/Organic Chemistry/Inorganic Chemistry/ Food Science and Technology/ Food and Nutraceuticals with 55 % Marks or B.Tech in Food Technology/ Chemical Engineering with first class or equivalent.
Eligibility for Project Fellow: candidate should have M.Sc in Chemistry with 55% marks or first class M. Pharmacy in pharmaceutical Chemistry/Medicinal Chemistry.
Eligibility for Project Assistant Level I: candidate should have B.Sc in Medicinal/ Non Medicinal with 55% Marks.
Eligible candidates can walk in for the interview at ‘CSIR- IHBT, Palampur (H.P), on 20 July 2016 (09.30 AM).
Click here for Detailed Notification of CSIR IHBT Recruitment 2016
CSIR IHBT Recruitment 2016 for SRF, Project Fellow, and Project Assistant Posts – Vacancy Details
CSIR IHBT Vacancy Details:
- SRF - 01 Post
- Project Assistant Level- II - 04 Posts
- Project Fellow- 01 Post
- Project Assistant Level –I – 02 Posts
How to Apply: Walk in for the interview at ‘CSIR- IHBT, Palampur (H.P), on 20 July 2016 (09.30 AM).
Important dates:
Walk in Interview Date: 20 July 2016 (09.30AM)
Notification Details:
Advertisement No: 08/2016
| Important Links | |
| Detailed Notification | |
| Official Website | |
Prepare This Exam with Unique Study Materials
Evaluate Your Preparation with Exam Quiz Online
Have query about this Notification? Click Here to Discuss
Comments
All Comments (0)
Join the conversation